Delta-8 THC exploded onto the scene in 2019, followed by delta-10 THC, THC-O acetate and HHC in 2020 and 2021.
While state regulatory agencies have opted for a whack-a-mole approach that focuses on controlling one cannabinoid at a time, the federal government has been largely silent on the legal status of hemp-derived cannabinoids.
Marijuana products technically aren’t eligible for federal trademarks because the plant is illegal under the Controlled Substances Act.
But that doesn’t mean cannabis businesses can’t protect their intellectual property and build brand awareness through patents and federal trademarks—the latter is applicable if the application doesn’t involve a plant-touching side of the business.
The U.S. Drug Enforcement Administration has offered federal lawmakers a rare glimpse into the ongoing marijuana rescheduling process.
A New Mexico congressman is pressing the U.S. Department of Homeland Security to account for what regulated marijuana operators claim is a rash of seizures of state-legal cannabis at Customs and Border Protection checkpoints.
The U.S. Drug Enforcement Administration will sign off on moving marijuana to Schedule 3 of the Controlled Substances Act, one federal lawmaker believes.
Beverage alcohol company Constellation Brands has converted its shares in Canadian cannabis company Canopy Growth Corp. into new exchangeable shares.
There’s “no reason” for the U.S. Drug Enforcement Administration to delay its long-awaited decision on moving marijuana from Schedule 1 to Schedule 3 of the Controlled Substances Act, the head of the Food and Drug Administration told a House committee.
Colorado’s marijuana cultivators now have freedom to procure genetics from a wider variety of sources.
Moving marijuana to Schedule 3 of the Controlled Substances Act, as Biden administration health officials have recommended, violates U.S. promises to other countries.
Congressional Republicans should oppose marijuana reform, including banking protections, because MJ is a “dangerous, addictive … gateway drug,” according to a GOP policy memo.
President Joe Biden or a successor could reschedule psychedelics like marijuana, but only if states create the right psilocybin policies.
